1 Contact Hour(s)
Wednesday, March 1, 2023
Monday, September 1, 2025
ACPE Expiration Date
Sunday, March 1, 2026
As rates of polypharmacy rise and medication regimens become more complex, the risk of potential CYP-mediated drug-drug interactions is continuously growing. Additionally, the understanding of polymorphism and epigenetics is providing insight into how changes in CYP genes may be responsible for inter-individual variations in these interactions, disease susceptibility, and the therapeutic efficacy of drugs. Cytochrome P450 System Part I reviews the structure, function, and mechanism of CYP450 enzymes in facilitating metabolism and drug interactions; we highlight the most important isoforms involved in drug interactions.
Note: this program is available in two formats. For the printout, please click the link marked as handout. For an interactive web page, please click the URL option to access the direct link.
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.
CDE, PharmD, PhD
Volunteer Pharmacist, CommunityHealth
This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).